As the knockdown of PIK3C2B in human leukemia CCRF-CEM cells decreased sensitivity to 6-TG in comparison to control (93), lacking or reduced expression of Pik3c2b mRNA in 4T1 might explain the resistance to 6-TG treatment. Here, PIK3C2B is linked to leukemia.